Table 2 General characteristic of PJS and control groups used in this study
Characteristics | PJS cases (N = 50) a | Control (N = 50) a |
|---|---|---|
Age (years) | ||
≤ 20 | 16 (32%) | 2 (4%) |
21–30 | 15 (30%) | 8 (16%) |
31–50 | 18 (36%) | 22 (44%) |
> 50 | 1 (2%) | 18 (36%) |
Gender | ||
Female | 20 (40%) | 15 (30%) |
Male | 30 (60%) | 35 (70%) |
Polyp/biopsy location | ||
Stomach | 2 (4%) | 0 |
Intestine | 32 (64%) | 6 (12%) |
Colon | 16 (32%) | 44 (88%) |
GI Malignancies | ||
Yes | 8 (16%) | 0 |
No | 42 (84%) | 50 (100%) |
Family History | ||
Yes | 27 (54%) | 0 |
No | 23 (46%) | 50 (100%) |
LKB1 germline mutation | ||
Yes | 26 (72.2%) | 0 |
No | 10 (27.8%) | 50 (100%) |